XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Spyce Performance Stock Units
Common Stock
Common Stock
Spyce Performance Stock Units
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 25, 2022     111,132,993      
Beginning balance at Dec. 25, 2022 $ 541,226   $ 111   $ 1,212,716 $ (671,601)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (113,384)         (113,384)
Issuance of common stock related to restricted shares (in shares)     587,078      
Stock-based compensation expense 49,532       49,532  
Exercise of stock options (in shares)     929,963      
Exercise of stock options 5,389   $ 2   5,387  
Shares repurchased for employee tax withholding (in shares)     (10,888)      
Shares repurchased for employee tax withholding (166)       (166)  
Ending balance (in shares) at Dec. 31, 2023     112,639,146      
Ending balance at Dec. 31, 2023 482,597   $ 113   1,267,469 (784,985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (90,373)         (90,373)
Issuance of common stock related to restricted shares (in shares)     479,078      
Stock-based compensation expense 39,024       39,024  
Issuance of common stock related to performance stock units   $ 2   $ 2    
Issuance of common stock related to performance stock units (in shares)     208,042 1,800,000    
Issuance of common stock related to Spyce milestone achievement $ 2,132       2,132  
Exercise of stock options (in shares) 1,990,576   1,990,576      
Exercise of stock options $ 12,765   $ 2   12,763  
Shares repurchased for employee tax withholding (in shares)     (531)      
Shares repurchased for employee tax withholding (2)       (2)  
Ending balance (in shares) at Dec. 29, 2024     117,116,311      
Ending balance at Dec. 29, 2024 446,145   $ 117   1,321,386 (875,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (134,065)         (134,065)
Issuance of common stock related to restricted shares (in shares)     690,957      
Stock-based compensation expense 36,475       36,475  
Issuance of common stock related to Spyce milestone achievement $ 4,709       4,709  
Issuance of common stock related to Spyce milestone achievement (in shares) 242,722          
Exercise of stock options (in shares) 408,345   408,345      
Exercise of stock options $ 3,120   $ 1   3,119  
Shares repurchased for employee tax withholding (in shares)     (9,918)      
Shares repurchased for employee tax withholding (259)       (259)  
Ending balance (in shares) at Dec. 28, 2025     118,448,417      
Ending balance at Dec. 28, 2025 $ 356,125   $ 118   $ 1,365,430 $ (1,009,423)